Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner

Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases

(2015) Marina Gazdic et al.   Stem Cell Reviews and Reports

Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model

(2015) Hiroyasu Ito et al.   Oncotarget

Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases

(2015) Marina Gazdic et al.   Stem Cell Reviews and Reports

Metformin aggravates immune-mediated liver injury in mice

(2014) Vladislav Volarevic et al.   ARCHIVES OF TOXICOLOGY

Mesenchymal Stem Cells Use IDO to Regulate Immunity in Tumor Microenvironment

(2014) W. Ling et al.   CANCER RESEARCH

Mesenchymal stem cells suppress CD8+T cell-mediated activation by suppressing natural killer group 2, member D protein receptor expression and secretion of prostaglandin E2, indoleamine 2, 3-dioxygenase and transforming growth factor-β

(2014) Mingfen Li et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Gal-3 regulates the capacity of dendritic cells to promote NKT-cell-induced liver injury

(2014) Vladislav Volarevic et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

 -Galactosylceramide but Not Phenyl-Glycolipids Induced NKT Cell Anergy and IL-33-Mediated Myeloid-Derived Suppressor Cell Accumulation via Upregulation of egr2/3

(2014) J.-R. Huang et al.   JOURNAL OF IMMUNOLOGY

Paracrine Effect of Mesenchymal Stem Cells Derived from Human Adipose Tissue in Bone Regeneration

(2014) Itali Linero et al.   PLoS One

Concise Review: Therapeutic Potential of Mesenchymal Stem Cells for the Treatment of Acute Liver Failure and Cirrhosis

(2014) Vladislav Volarevic et al.   STEM CELLS

Immunological characterization of multipotent mesenchymal stromal cells—The International Society for Cellular Therapy (ISCT) working proposal

(2013) Mauro Krampera et al.   CYTOTHERAPY

MicroRNA-146a Feedback Suppresses T Cell Immune Function by Targeting Stat1 in Patients with Chronic Hepatitis B

(2013) S. Wang et al.   JOURNAL OF IMMUNOLOGY

Mesenchymal stem cells: a double-edged sword in regulating immune responses

(2012) W Li et al.   CELL DEATH AND DIFFERENTIATION

How mesenchymal stem cells interact with tissue immune responses

(2012) Yufang Shi et al.   TRENDS IN IMMUNOLOGY

Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice

(2011) Vladislav Volarevic et al.   HEPATOLOGY

Protective role of IL-33/ST2 axis in Con A-induced hepatitis

(2011) Vladislav Volarevic et al.   JOURNAL OF HEPATOLOGY

Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation

(2011) Moïra François et al.   MOLECULAR THERAPY

Ability of IDO To Attenuate Liver Injury in  -Galactosylceramide-Induced Hepatitis Model

(2010) H. Ito et al.   JOURNAL OF IMMUNOLOGY

Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10

(2009) Seung-Ha Yang et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression

(2009) Guangwen Ren et al.   STEM CELLS

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

(2008) Guangwen Ren et al.   Cell Stem Cell

Hepatic NKT cells: friend or foe?

(2008) Mark G. Swain   CLINICAL SCIENCE

Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase

(2008) Alberto Molano et al.   IMMUNOLOGY LETTERS

Reciprocal Interactions Between Human Mesenchymal Stem Cells and γδ T Cells Or Invariant Natural Killer T Cells

(2008) Ignazia Prigione et al.   STEM CELLS